|
1
|
Clifton BA, Neill JS and Anderson MD:
Treatment of Shh medulloblastoma with extraneural metastasis to the
bone marrow. Current problems in cancer: Case Reports.
4:1001042021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shinden Y, Sugimachi K, Tanaka F,
Fujiyoshi K, Kijima Y, Natsugoe S and Mimori K: Clinicopathological
characteristics of disseminated carcinomatosis of the bone marrow
in breast cancer patients. Mol Clin Oncol. 8:93–98. 2018.PubMed/NCBI
|
|
3
|
La Gioia A, Fiorini F and La Gioia N: Bone
marrow involvement by metastatic invasive lobular breast cancer.
Int J Lab Hematol. 44:40–41. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fan HJ, Huang C, Su Y, Wang XD, Zhou YC,
Duan C, Zhao W, Zhao Q, Jin M and Ma XL: Clinical characteristics
and prognosis of high-risk neuroblastoma with bone marrow
metastasis in children. Zhonghua Er Ke Za Zhi. 57:863–869. 2019.(In
Chinese). PubMed/NCBI
|
|
5
|
Rani HS, Hui M, Manasa P, Uppin SG, Uppin
MS, Paul TR and Sadashivudu G: Bone marrow metastasis of solid
tumors: A study of 174 cases over 2 decades from a single
institution in India. Indian J Hematol Blood Transfus. 38:8–14.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Edwards IR and Aronson JK: Adverse drug
reactions: Definitions, diagnosis, and management. Lancet.
356:1225–1229. 2000. View Article : Google Scholar
|
|
7
|
Rana NA, Mahmood A, Robert HM, Zahir S,
Asghar MB and Riaz S: Laboratory evaluation and pathological
features of bone marrow metastasis in non-haematological
malignancies. J Coll Physicians Surg Pak. 32:1367–1369. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hofbauer LC, Bozec A, Rauner M, Jakob F,
Perner S and Pantel K: Novel approaches to target the
microenvironment of bone metastasis. Nat Rev Clin Oncol.
18:488–505. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hong YM, Yoon KT, Cho M, Kang DH, Kim HW,
Choi CW, Park SB, Heo J, Woo HY, Lim W and Islam SMB: Bone marrow
metastasis presenting as bicytopenia originating from
hepatocellular carcinoma. Clin Mol Hepatol. 22:267–271. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi XB, Deng WX and Jin FX: Bone marrow
metastatic neuroendocrine carcinoma with unknown primary site: A
case report and review of the literature. World J Clin Cases.
10:11074–11081. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kopp HG, Krauss K, Fehm T, Staebler A,
Zahm J, Vogel W, Kanz L and Mayer F: Symptomatic bone marrow
involvement in breast cancer-clinical presentation, treatment, and
prognosis: A single institution review of 22 cases. Anticancer Res.
31:4025–4030. 2011.PubMed/NCBI
|
|
12
|
Pan H, Gray R, Braybrooke J, Davies C,
Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, et
al: 20-year risks of breast-cancer recurrence after stopping
endocrine therapy at 5 years. N Engl J Med. 377:1836–1846. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park SH, Keller ET and Shiozawa Y: Bone
marrow microenvironment as a regulator and therapeutic target for
prostate cancer bone metastasis. Calcif Tissue Int. 102:152–162.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ripp J, Diab O, Woodroof J and Sun W:
Colorectal adenocarcinoma presenting with isolated metastasis to
the cortical bone and bone marrow: A case report and review of the
literature. Clin Colorectal Cancer. 20:e150–e154. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jafari A, Fairfield H, Andersen TL and
Reagan MR: Myeloma-bone marrow adipocyte axis in tumour survival
and treatment response. Br J Cancer. 125:775–777. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fairfield H, Dudakovic A, Khatib CM,
Farrell M, Costa S, Falank C, Hinge M, Murphy CS, DeMambro V,
Pettitt JA, et al: Myeloma-modified adipocytes exhibit metabolic
dysfunction and a senescence-associated secretory phenotype. Cancer
Res. 81:634–527. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dello Spedale Venti M, Palmisano B,
Donsanten S, Farinacci G, Adotti F, Coletta I, Serafini M, Corsi A
and Riminucci M: Morphological and immunophenotypical changes of
human bone marrow adipocytes in marrow metastasis and
myelofibrosis. Front Endocrinol (Lausanne). 13:8823792022.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
DA Silva A, Levy C, Allouache D, Hrab I,
Morel A, Faveyrial A, Gunzer K, Johnson A, Segura C, Licaj I, et
al: Efficacy and safety of weekly paclitaxel in breast cancer with
symptomatic bone marrow infiltration. Anticancer Res. 40:2955–2960.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Braun S, Vogl FD, Janni W, Marth C,
Schlimok G and Pantel K: Evaluation of bone marrow in breast cancer
patients: Prediction of clinical outcome and response to therapy.
Breast. 12:397–404. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Buschhaus JM, Humphries BA, Eckley SS,
Robison TH, Cutter AC, Rajendran S, Haley HR, Bevoor AS, Luker KE
and Luker GD: Targeting disseminated estrogen-receptor-positive
breast cancer cells in bone marrow. Oncogene. 39:5529–5662. 2020.
View Article : Google Scholar
|
|
21
|
Arya L, Sundriyal D, Bhandari R,
Srivastava R and Sehrawat A: Bone marrow metastases from solid
organ cancer in adults. Indian J Surg Oncol. 12:545–548. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mora J: Autologous stem-cell
transplantation for high-risk neuroblastoma: Historical and
critical review. Cancers (Basel). 14:25722022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moreno L, Guo D, Irwin MS, Berthold F,
Hogarty M, Kamijo T, Morgenstern D, Pasqualini C, Ash S, Potschger
U, et al: A nomogram of clinical and biologic factors to predict
survival in children newly diagnosed with high-risk neuroblastoma:
An international neuroblastoma risk group project. Pediatr Blood
Cancer. 68:e287942021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Park JR, Kreissman SG, London WB, Naranjo
A, Cohn SL, Hogarty MD, Tenney SC, Haas-Kogan D, Shaw PJ, Kraveka
JM, et al: Effect of tandem autologous stem cell transplant vs
singletransplant on event-free survival in patients with high-risk
neuroblastoma: A randomized clinical trial. JAMA. 322:746–755.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Demir L, Akyol M, Bener S, Payzin KB,
Erten C, Somali I, Can A, Dirican A, Bayoglu V, Kucukzeybek Y, et
al: Prognostic evaluation of breast cancer patients with evident
bone marrow metastasis. Breast J. 20:279–287. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hiroshige T and Eguchi Y: Prostate cancer
with disseminated carcinomatosis of the bone marrow: Two case
reports. Mol Clin Oncol. 7:233–236. 2017.PubMed/NCBI
|
